BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $8,743,000 | +12.2% | 60,000 | -8.7% | 0.26% | +46.1% |
Q1 2022 | $7,793,000 | -22.2% | 65,725 | -9.5% | 0.18% | -20.4% |
Q4 2021 | $10,011,000 | -6.4% | 72,645 | -5.7% | 0.23% | -1.7% |
Q3 2021 | $10,696,000 | +20.6% | 77,000 | -15.7% | 0.23% | +17.9% |
Q2 2021 | $8,870,000 | +46.3% | 91,372 | +3.0% | 0.20% | +46.6% |
Q1 2021 | $6,063,000 | +1.9% | 88,711 | +27.8% | 0.13% | +15.7% |
Q4 2020 | $5,948,000 | +10.2% | 69,396 | -16.4% | 0.12% | -20.1% |
Q3 2020 | $5,396,000 | -11.1% | 83,000 | -0.0% | 0.14% | -17.2% |
Q2 2020 | $6,069,000 | +36.4% | 83,018 | -36.5% | 0.17% | 0.0% |
Q1 2020 | $4,449,000 | -14.0% | 130,737 | +37.6% | 0.17% | +104.7% |
Q4 2019 | $5,172,000 | +7.8% | 95,000 | -17.4% | 0.08% | -12.4% |
Q3 2019 | $4,799,000 | -16.4% | 115,000 | -12.2% | 0.10% | -36.2% |
Q2 2019 | $5,737,000 | +1014.0% | 131,000 | +1210.0% | 0.15% | +1069.2% |
Q1 2019 | $515,000 | +26.5% | 10,000 | -9.1% | 0.01% | -23.5% |
Q4 2018 | $407,000 | -27.7% | 11,000 | -26.7% | 0.02% | +13.3% |
Q3 2018 | $563,000 | +78.2% | 15,000 | +87.5% | 0.02% | +87.5% |
Q2 2018 | $316,000 | – | 8,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |